Cited by 3Systemic Lupus Erythematosus ResearchBlood Coagulation and Thrombosis MechanismsClinical Laboratory Practices and Quality Control

Guidelines for Lupus Anticoagulant Testing in South Africa

Open access
Bailly, J., Louw, S. (Susan), De Koker, A. (Annemarie), Potgieter, J.J.C, Coetzee, M.J., Chapanduka, Z.C. (Zivanai Cuthbert), Opie, J.J.·2020·The Journal of Medical Laboratory Science and Technology of South Africa

Abstract

However, the LA is a misnomer since it is associated with thrombosis in vivo, and most commonly is detected as an incidental, transient laboratory finding associated with conditions such as autoimmune diseases, infections and even in healthy individuals.Repeatedly positive LA testing in the setting of thrombotic and/or obstetric complications is required to diagnose the antiphospholipid syndrome (APS).This review intends to provide clarity on LA testing in the South African context and to provide a national guideline in order to standardise LA testing, interpretation and reporting of results.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.36303/jmlstsa.2020.2.1.39

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Clotting times of screening, mixing, and confirmatory procedures are prone to inter- and intra-assay variability; therefore, it is recommended to normalize these clotting times by generating a ratio between test clotting time and NPP clotting time.

    “Clotting times of screening, mixing, and confirmatory procedures are prone to inter- (between same-principle tests offered by different manufacturers) and intra-assay (between batches of the same reagent) variability [25]; for this reason, it is recommended to normalize a screening, mixing, and confirmatory clotting time, generating a ratio between test clotting time and NPP clotting time [9,36,48”

    From Lupus Anticoagulant Detection under the Magnifying Glass (2023) · cites this paper as [54]

    Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 16

  1. Love PE, Santoro SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. Ann Intern Med. 1990;112(9):682-98. https:// doi.org/10.7326/0003-4819-112-9-682. · DOI
  2. Arachchillage DRJ, Laffan M. Pathogenesis and management of antiphospholipid syndrome. Br J Haematol. 2017;178(2):181-95. https://doi. org/10.1111/bjh.14632. · DOI
  3. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med. 2002;346(10):752-63. https://doi.org/10.1056/NEJMra002974. · DOI
  4. Limper M, Scire CA, Talarico R, et al. Antiphospholipid syndrome: state of the art on clinical practice guidelines. RMD Open. 2018;4(Suppl 1):e000785. https://doi. org/10.1136/rmdopen-2018-000785. · DOI
  5. Chaturvedi S, McCrae KR. The antiphospholipid syndrome: still an enigma. Hematology Am Soc Hematol Educ Program. 2015;2015:53-60. https://doi. org/10.1182/asheducation-2015.1.53. · DOI · Paper page
  6. Corban MT, Duarte-Garcia A, McBane RD, et al. Antiphospholipid Syndrome: Role of Vascular Endothelial Cells and Implications for Risk Stratification and Targeted Therapeutics. J Am Coll Cardiol. 2017;69(18):2317-30. https://doi.org/10.1016/j. jacc.2017.02.058. · DOI
  7. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295-306. https://doi. org/10.1111/j.1538-7836.2006.01753.x. · DOI · Paper page
  8. Keeling D, Mackie I, Moore GW, Greer IA, Greaves M, British Committee for Standards in Haematology. Guidelines on the investigation and management of antiphospholipid syndrome. Br J Haematol. 2012;157(1):47-58. https://doi. org/10.1111/j.1365-2141.2012.09037.x. · DOI · Paper page
  9. Pengo V, Banzato A, Bison E, et al. Laboratory testing for antiphospholipid syndrome. Int J Lab Hematol. 2016;38(Suppl 1):27-31. https://doi.org/10.1111/ ijlh.12507. · DOI
  10. Lim W. Antiphospholipid syndrome. Hematology Am Soc Hematol Educ Program. 2013;2013:675-80. https://doi.org/10.1182/asheducation-2013.1.675. · DOI
  11. Devreese KM. Interpretation of normal plasma mixing studies in the laboratory diagnosis of lupus anticoagulants. Thromb Res. 2007;119(3):369-76. https://doi. org/10.1016/j.thromres.2006.03.012. · DOI · Paper page
  12. Favaloro EJ, Mohammed S, Curnow J, Pasalic L. Laboratory testing for lupus anticoagulant (LA) in patients taking direct oral anticoagulants (DOACs): potential for false positives and false negatives. Pathology. 2019;51(3):292-300. https://doi.org/10.1016/j.pathol.2018.11.008. · DOI · Paper page
  13. Hoxha A, Banzato A, Ruffatti A, Pengo V. Detection of lupus anticoagulant in the era of direct oral anticoagulants. Autoimmun Rev. 2017;16(2):173-8. https://doi. org/10.1016/j.autrev.2016.12.010. · DOI
  14. Chang S. More on: normal plasma mixing studies in the laboratory diagnosis of lupus anticoagulant. J Thromb Haemost. 2004;2(8):1480-1. https://doi. org/10.1111/j.1538-7836.2004.00847.x. · DOI · Paper page
  15. Rosner E, Pauzner R, Lusky A, Modan M, Many A. Detection and quantitative evaluation of lupus circulating anticoagulant activity. Thromb Haemost. 1987;57(2):144-7. https://doi.org/10.1055/s-0038-1651083. · DOI
  16. Devreese KM, Pierangeli SS, De Laat B, et al. Testing for antiphospholipid antibodies with solid phase assays: guidance from the SSC of the ISTH. J Thromb Haemost. 2014;12(5):792-5. https://doi.org/10.1111/jth.12537. · DOI · Paper page

Cited by

Sorted by citations

Authors
Bailly, J., Louw, S. (., De Koker, A. (., Potgieter, J. J. C., Coetzee, M. J., Chapanduka, Z. C. (. C., & Opie, J. J.
Affiliations
  • University of Cape Town (ZA)
  • University of the Witwatersrand
  • University of Cape Town
  • University of Pretoria (ZA)
  • University of the Free State (ZA)
  • Stellenbosch University (ZA)
Venue
The Journal of Medical Laboratory Science and Technology of South Africa
Publisher
AOSIS
Published
2020-01
Volume
2
Issue
1
Pages
6-12
ISSN
2664-2549 (ISSN-L)
OpenAlex
W3042381477
Cited by
3
References
5
Citations by year
2025: 1 · 2023: 1 · 2022: 1
FWCI
0.38
Type
journal article
Language
en
Open access
Locations
  • Journal of Medical Laboratory Science & Technology of South Africa (publishedVersion, cc-by-nc-nd)
  • SUNScholar (Stellenbosch University) (submittedVersion)
Topics
  • Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
  • Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
  • Health Sciences › Medicine › Physiology › Clinical Laboratory Practices and Quality Control
Keywords
lupus anticoagulant, antiphospholipid syndrome, thrombosis, pregnancy complications, South Africa

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review